Technology News and Research

RSS

Penn researchers demonstrate new app to optimize acute stroke care

Stroke researchers from the Perelman School of Medicine at the University of Pennsylvania will unveil a map demonstrating geographic hotspots of increased stroke mortality across the United States, among a series of stroke studies being presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

29 Apr 2014

GW University establishes new online integrative medicine program

The George Washington University (GW) School of Medicine and Health Sciences is pleased to announce the establishment of a new, online Integrative Medicine Program, in partnership with the Metabolic Medical Institute.

29 Apr 2014

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing and commercializing transformative therapeutics using its proprietary ARCUSTM technology, today announced positive results from a Phase 2b clinical trial of CVT-301, an inhaled formulation of levodopa (L-dopa).

29 Apr 2014

Oregon opts for federal exchange

The board overseeing Oregon's nonfunctional health insurance exchange unanimously approved the Obama administration's plan Friday to take over the marketplace, making Oregon the first state to drop its enrollment website for healthcare.gov.

29 Apr 2014

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Inherited mutations in the BRCA1 or BRCA2 tumor suppressor genes are by far the most frequent contributors to hereditary cancer risk in the human population, often causing breast or ovarian cancer in young women of child-bearing age.

29 Apr 2014

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Highland Therapeutics Inc., an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD").

28 Apr 2014

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Truven Health Analytics, a leading provider of healthcare analytics and data solutions and services, today announced the acquisition of Fortel Analytics' healthcare fraud technology. The acquisition gives Truven Health exclusive access to a breakthrough suite of predictive solutions, analysis methods and analytic technology designed to quickly identify suspicious patterns in healthcare insurance claims data before claims are ever paid.

28 Apr 2014

Monarch Medical Technologies gets FDA clearance for new glucose management solution

Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.

28 Apr 2014

First Edition: April 28, 2014

Today's headlines include a number of stories examining the impact of the health law in various states.

28 Apr 2014

Agenus enters into agreement with Merck for development of therapeutic antibodies

Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.

28 Apr 2014

Scientists use analysis of epigenetic marks on DNA to measure baby's development in womb

An international study, involving scientists at the University of Southampton, has used an analysis of epigenetic marks on DNA to measure how much a baby's development in the womb is determined by the genes inherited from the parents, as compared with the mother's nutrition, mental health and lifestyle.

28 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

Sinovac Biotech commits to commercialize Sabin Inactivated Polio Vaccine in China

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines, announced today that it has entered into a license agreement with Intravacc (Institute for Translational Vaccinology) from The Netherlands to develop and commercialize the Sabin Inactivated Polio Vaccine (sIPV) for distribution to China and other countries.

28 Apr 2014

Mauna Kea receives regulatory approval in Japan for Cellvizio flagship product

Mauna Kea Technologies, leader in the optical biopsy market, announced today it received regulatory approval in Japan for the company's Cellvizio flagship product.

28 Apr 2014

MedScope partners to provide PERS devices and services to Visiting Angels' franchisees

MedScope, the leading provider of high-tech medical alert systems, and Visiting Angels, one of the nation's largest in-home care companies, have jointly announced a partnership to provide MedScope's full array of Personal Emergency Response System (PERS) devices and services to Visiting Angels' franchisees.

28 Apr 2014

Cover Oregon poised to join federal exchange

With encouragement from the Obama administration, an Oregon panel recommended Thursday that the state pull the plug on its glitch-ridden website and switch to the federal insurance marketplace. The final decision is expected to be made Friday by its exchange board. Oregon built what is widely regarded as the worst-functioning state exchange in the nation.

26 Apr 2014

Novel technique tests brain waves as external stimuli are processed

Have you ever accidently missed a red light or a stop sign? Or have you heard someone mention a visible event that you passed by but totally missed seeing?

26 Apr 2014

Virginia Tech scientist receives grant to develop technique to detect subcellular location of protein

Virginia Tech chemical engineer Chang Lu and his colleagues have used a National Science Foundation grant to develop a technique to detect subcellular location of a protein.

26 Apr 2014

MGH investigators develop next-generation genome editing system

A next-generation genome editing system developed by Massachusetts General Hospital investigators substantially decreases the risk of producing unwanted, off-target gene mutations. In a paper receiving online publication in Nature Biotechnology, the researchers report a new CRISPR-based RNA-guided nuclease technology that uses two guide RNAs, significantly reducing the chance of cutting through DNA strands at mismatched sites.

26 Apr 2014

Engineering breakthrough allows cancer researchers to create living tumors

Drexel's Wei Sun, PhD, Albert Soffa chair professor in the College of Engineering, has devised a method for 3D printing tumors that could soon be taking cancer research out of the petri dish.

26 Apr 2014

Technology News and Research

Penn researchers demonstrate new app to optimize acute stroke care

GW University establishes new online integrative medicine program

Civitas reports positive results from CVT-301 Phase 2b trial for treatment of Parkinson's disease

Oregon opts for federal exchange

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Highland subsidiary begins enrolment in Phase III study of HLD-200 in pediatric ADHD patients

Truven Health Analytics announces acquisition of Fortel Analytics' healthcare fraud technology

Monarch Medical Technologies gets FDA clearance for new glucose management solution

First Edition: April 28, 2014

Agenus enters into agreement with Merck for development of therapeutic antibodies

Scientists use analysis of epigenetic marks on DNA to measure baby's development in womb

Voluntis closes €20.75 million ($29 million) Series D financing round

Sinovac Biotech commits to commercialize Sabin Inactivated Polio Vaccine in China

Mauna Kea receives regulatory approval in Japan for Cellvizio flagship product

MedScope partners to provide PERS devices and services to Visiting Angels' franchisees

Cover Oregon poised to join federal exchange

Novel technique tests brain waves as external stimuli are processed

Virginia Tech scientist receives grant to develop technique to detect subcellular location of protein

MGH investigators develop next-generation genome editing system

Engineering breakthrough allows cancer researchers to create living tumors

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News